Outcome in 203 patients (PTS) with relapsed or refractory B-cell chronic lymphocytic leukemia (CLL) with salvage therapy (RX): Retreatment with fludarabine (FLU).

被引：0
|
作者：
Thomas, D [1 ]
O'Brien, S [1 ]
Kantarjian, H [1 ]
Giles, FJ [1 ]
Lerner, S [1 ]
Keating, MJ [1 ]
机构：
[1] Univ Texas, Md Anderson Canc Ctr, Leukemia Sect, Houston, TX USA
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
419
引用
收藏
页码：102A / 103A
页数：2
相关论文
共 50 条
  • [21] Effectiveness of fludarabine in advanced B-cell chronic lymphocytic leukemia
    Montillo, M
    Tedeschi, A
    Delfini, C
    Olivieri, A
    DAdamo, F
    Leoni, P
    TUMORI, 1995, 81 (06) : 419 - 423
  • [22] Fludarabine uptake mechanisms in B-cell chronic lymphocytic leukemia
    Molina-Arcas, M
    Bellosillo, B
    Casado, FJ
    Montserrat, E
    Gil, J
    Colomer, D
    Pastor-Anglada, M
    BLOOD, 2003, 101 (06) : 2328 - 2334
  • [23] Acquired Mutations in Patients (Pts) with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) That Progressed in the ALPINE Study
    Brown, Jennifer R.
    Li, Jessica
    Eichhorst, Barbara F.
    Lamanna, Nicole
    O'Brien, Susan M.
    Tam, Constantine S.
    Qiu, Luqui
    Ramakrishnan, Vanitha
    Huang, Ruiqi
    Shi, Yang
    Idoine, Adam
    Salmi, Tommi
    Cohen, Aileen Cleary
    Shadman, Mazyar
    BLOOD, 2023, 142
  • [24] A pilot trial of rituximab and alemtuzumab combination therapy in patients with relapsed and/or refractory chronic lymphocytic leukemia (CLL)
    Nabhan, C
    Patton, D
    Gordon, LI
    Riley, MB
    Kuzel, T
    Tallman, MS
    Rosen, ST
    LEUKEMIA & LYMPHOMA, 2004, 45 (11) : 2269 - 2273
  • [25] Leukemic meningitis in B-cell chronic lymphocytic leukemia (CLL).
    Caldera, H
    Raez, L
    Hidron, A
    Henao, A
    Goodman, M
    BLOOD, 1998, 92 (10) : 260B - 260B
  • [26] Mathematical model of B-cell chronic lymphocytic leukemia (CLL)
    Martinis, M
    Vitale, B
    Zlatic, V
    Dobrosevic, B
    Dodig, K
    PERIODICUM BIOLOGORUM, 2005, 107 (04) : 445 - 450
  • [27] Allelotyping in B-cell chronic lymphocytic leukemia (B-CLL)
    Novak, U
    Tobler, A
    Fey, MF
    LEUKEMIA & LYMPHOMA, 2004, 45 (05) : 887 - 896
  • [28] Phase I/II study of oxaliplatin, fludarabine, cytarabine, and rituximab in patients (OFAR2) with Richter's syndrome (RS), and relapsed or refractory B-cell chronic lymphocytic leukemia (CLL)
    Tsimberidou, A. M.
    Wierda, W. G.
    Plunkett, W. K.
    O'Brien, S.
    Lerner, S.
    Smith, S. C.
    Kantarjian, H. M.
    Keating, M. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [29] Efficacy and safety of fludarabine and cyclophosphamide combined therapy in patients with refractory/recurrent B-cell chronic lymphocytic leukaemia (B-CLL) - Polish multicentre study
    Kowal, M
    Dmoszynska, A
    Lewandowski, K
    Hellmann, A
    Wegrzyn, J
    Skotnicki, AB
    Wolowiec, D
    Kuliczkowski, K
    Piszcz, J
    Kloczko, J
    Roznowski, K
    Komarnickif, M
    LEUKEMIA & LYMPHOMA, 2004, 45 (06) : 1159 - 1165
  • [30] Combination of fludarabine (FAMP) cyclophosphamide (CTX) and alemtuzumab for patients with relapsed chronic lymphocytic leukemia (CLL).
    Tedeschi, A
    Montillo, M
    Miqueleiz, S
    Draisci, M
    Ricci, F
    Scarpati, B
    Mura, ME
    Crugnola, M
    Morra, E
    BLOOD, 2005, 106 (11) : 341B - 341B
12345